Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on March 3, 2025

Xraised Interviews Milena Stankovic on Healing from Toxic Relationships and the Power of Self-Love

Xraised Interviews Milena Stankovic on Healing from Toxic Relationships and the Power of Self-Love

FORT LAUDERDALE, FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- Xraised recently hosted an exclusive interview with Milena “Mila ” Stankovic, Co-Founder of STAR Network, a 501c3 dedicated to helping survivors of toxic abusive relationships …

H2Ocean Healing Rinse is Elevating DSO Success with Excellent Post-Op Recovery and Healing Outcomes

H2Ocean Healing Rinse is Elevating DSO Success with Excellent Post-Op Recovery and Healing Outcomes

The world's first and only patented sea salt based mouthwash that is setting new gold standards for oral care in the DSO industry. STUART , FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- H2Ocean is setting a new global benchmark with Healing …

Forthright Technology Partners makes CRN's 2025 MSP 500 / Pioneer 250

Forthright Technology Partners makes CRN's 2025 MSP 500 / Pioneer 250

The Pioneer 250 recognizes innovative managed services companies that focus on solutions aimed at the mid-market and small corporate space. WESTON, FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- Forthright Technology Partners is proud to have …

Dr. Tarek Assi Honored as Top Specialist For Dental Implants

Dr. Tarek Assi Honored as Top Specialist For Dental Implants

Coral Springs, Florida Dental Specialist Selected for the "America's Best Dentists” Award for 2025 CORAL SPRINGS, FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- Dr. Tarek Assi, DMD, FAGD, FAAID, DIDIA, DICOI, DABOI has been named to the …

H2Ocean’s Sea Salt based Natural Products Are Proudly Made in the USA, From Start to Finish Without Outsourcing

H2Ocean’s Sea Salt based Natural Products Are Proudly Made in the USA, From Start to Finish Without Outsourcing

H2Ocean stands as a prominent exemplar of American innovation, dedicated to developing natural sea salt based skin products that prioritize safety and quality. STUART, FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- H2Ocean, a pioneer in sea salt …

10 Local Childhood Cancer Nonprofits Unite to Celebrate Kids & Families at the Heroes Unite Superhero Family Picnic

10 Local Childhood Cancer Nonprofits Unite to Celebrate Kids & Families at the Heroes Unite Superhero Family Picnic

These 10 South Florida childhood cancer nonprofits are proving that collaboration is the key to making a real impact. MIAMI, FL, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- On Saturday, March 8, 2025, these organizations will come together to …

LeMaitre to Participate at Upcoming Investor Conferences in March

LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March. 37th Annual ROTH Conference Monday, March 17, 2025 The Laguna …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE, Australia and INDIANAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company’s late-stage and next-generation radiotherapeutic …

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 …

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed receipt of a non-binding proposal from Anne Wojcicki, Chief Executive …

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect …

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in March as follows: Barclays …

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech …

Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech & Services Conference

Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech & Services Conference

Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech …

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository corticotropin injection USP) ( …

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 Adjusted EBITDA of $21.0 million, increase …

Tenaya Therapeutics Announces Proposed Public Offering

Tenaya Therapeutics Announces Proposed Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …

Amwell makes inducement grant

Amwell makes inducement grant

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service